63 results
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction … such further inquiry or investigation into such facts or matters as it may see fit.
(h) The Trustee shall not be deemed to have notice of any Default
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
or investigation pending or, to the Company’s Knowledge, threatened against or affecting the Company, or any of its properties before or by any court … , court costs and reasonable attorneys’ fees and costs of investigation.
“Marketed Underwritten Offering” has the meaning assigned to such term
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
as could not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received notice of any investigation … or notice of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any Subsidiary, except
8-K
EX-10.2
gfa2ts8gz
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
8w7boucsbtpb0n0y
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
w11wv9682t7 nl6k0
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
mbfxs1pa6n1 yxfq0
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
13ac1c3
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
uh9ye7kwly
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
ktl oapde7xwio
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-4.2
oortbtlnwbvsu66
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.1
m15gwnp6yvz 6i3
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-1.1
zlh8rmdizas5i yus5a
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
g59dg6416hil
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
ve3c5d
28 Mar 22
Prospectus supplement for primary offering
4:53pm